Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy.
Jones, Thomas
Proto-Oncogene Proteins c-vav
Scenedesmus
United States Department of Veterans Affairs
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy.
Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy. Dis Esophagus. 2014 Jul; 27(5):418-23.
View in:
PubMed
subject areas
Androstadienes
Anti-Inflammatory Agents
Costs and Cost Analysis
Decision Trees
Deglutition Disorders
Dilatation
Endoscopy, Digestive System
Eosinophilic Esophagitis
Esophageal Stenosis
Fluticasone
Hospitalization
Humans
Metered Dose Inhalers
Tennessee
authors with profiles
Robert Kavitt